Quick Answer
IDEAYA Biosciences, Inc. reported Total Revenue of $218.71 million for fiscal year 2025.
IDEAYA Biosciences, Inc. Total Revenue — Annual History
| Fiscal Year | Total Revenue | YoY Change |
|---|---|---|
| 2025 | $218.71M | +3024.4% |
| 2024 | $7.00M | -70.1% |
| 2023 | $23.39M | -54.1% |
| 2022 | $50.93M | +82.3% |
| 2021 | $27.94M | +43.0% |
| 2020 | $19.54M | — |
| 2019 | $0.00 | — |
Quarterly Total Revenue
| Quarter Ending | Total Revenue | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $207.83M | — | — |
| September 30, 2024 | $0.00 | -100.0% | — |
| June 30, 2024 | $0.00 | -100.0% | — |
| March 31, 2024 | $0.00 | -100.0% | -100.0% |
| September 30, 2023 | $8.04M | -72.9% | +126.8% |
| June 30, 2023 | $3.54M | -39.4% | -55.0% |
| March 31, 2023 | $7.88M | -30.6% | -73.5% |
| September 30, 2022 | $29.70M | +230.9% | +407.6% |
- IDEAYA Biosciences, Inc. showed an increase of +3024.4% in Total Revenue compared to the prior fiscal year.
- The most recent figure is from IDEAYA Biosciences, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 17, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: